For 503A pharmacies, FDA reiterated a limited enforcement policy from its 2018 guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: the agency does not intend to take action where a compounder fills four or fewer prescriptions per calendar month of a drug that is essentially a copy of a commercially available drug
Key Specifications Telehealth with prescription : Yes Accepts insurance : No Consultation fee : $0 (included in package) Membership fee : No Medications available : Tirzepatide and semaglutide Pros and Cons Pros They offer a quick turnaround time
Adler AI, Stevens RJ, Manley SE, et al
I dont think the question is whether weight care, and GLP-1s specifically, should be available virtually
Research shows that oral semaglutide typically has a bioavailability of just 0.4% to 1%